Lipidomic Analysis of α-Synuclein Neurotoxicity Identifies Stearoyl CoA Desaturase as a Target for Parkinson Treatment
Author(s)
Fanning, Saranna; Haque, Aftabul; Imberdis, Thibaut; Baru, Valeriya; Barrasa, M. Inmaculada; Nuber, Silke; Termine, Daniel; Ramalingam, Nagendran; Ho, Gary P.H.; Noble, Tallie; Sandoe, Jackson; Lou, Yali; Landgraf, Dirk; Freyzon, Yelena; Newby, Gregory; Soldner, Frank; Terry-Kantor, Elizabeth; Kim, Tae-Eun; Hofbauer, Harald F.; Becuwe, Michel; Jaenisch, Rudolf; Pincus, David; Clish, Clary B.; Walther, Tobias C.; Farese, Robert V.; Srinivasan, Supriya; Welte, Michael A.; Kohlwein, Sepp D.; Dettmer, Ulf; Lindquist, Susan; Selkoe, Dennis; ... Show more Show less
DownloadAccepted version (2.212Mb)
Publisher with Creative Commons License
Publisher with Creative Commons License
Creative Commons Attribution
Terms of use
Metadata
Show full item recordAbstract
In Parkinson's disease (PD), α-synuclein (αS) pathologically impacts the brain, a highly lipid-rich organ. We investigated how alterations in αS or lipid/fatty acid homeostasis affect each other. Lipidomic profiling of human αS-expressing yeast revealed increases in oleic acid (OA, 18:1), diglycerides, and triglycerides. These findings were recapitulated in rodent and human neuronal models of αS dyshomeostasis (overexpression; patient-derived triplication or E46K mutation; E46K mice). Preventing lipid droplet formation or augmenting OA increased αS yeast toxicity; suppressing the OA-generating enzyme stearoyl-CoA-desaturase (SCD) was protective. Genetic or pharmacological SCD inhibition ameliorated toxicity in αS-overexpressing rat neurons. In a C. elegans model, SCD knockout prevented αS-induced dopaminergic degeneration. Conversely, we observed detrimental effects of OA on αS homeostasis: in human neural cells, excess OA caused αS inclusion formation, which was reversed by SCD inhibition. Thus, monounsaturated fatty acid metabolism is pivotal for αS-induced neurotoxicity, and inhibiting SCD represents a novel PD therapeutic approach. Keywords: Parkinson’s disease; synucleinopathy; alpha-synuclein; stearoyl-CoA-desaturase; unsaturated fatty acid; oleic acid; lipid droplets; diglyceride; triglyceride; tetramer; inclusions
Date issued
2018-12Department
Whitehead Institute for Biomedical Research; Massachusetts Institute of Technology. Department of Biology; Broad Institute of MIT and HarvardJournal
Molecular Cell
Publisher
Elsevier BV
Citation
Fanning, Saranna et al. "Lipidomic Analysis of α-Synuclein Neurotoxicity Identifies Stearoyl CoA Desaturase as a Target for Parkinson Treatment." Molecular Cell 73, 5 (March 2019): 1001-1014 © 2018 Elsevier Inc.
Version: Author's final manuscript
ISSN
1097-2765